The Power of Precision
Gene therapy research is critical to solving genetic diseases and advancing patient treatment. As the complementary fields of somatic gene therapy and cell-based therapy continue to develop rapidly, the design and commercialization of gene and cell therapies become a complex undertaking. Viral vectors are routinely utilized as a gene therapy delivery vehicle, with the quality of capsid proteins and nucleic acids integral to the safety and efficacy of this product.
A complete suite of instruments and solutions from SCIEX can help reduce some of that complexity and help you bring a safe, effective therapy to market sooner. Whether you are investigating ASOs, siRNAs, mRNAs, CRISPR, viral vector based gene therapies or cell-based therapies, SCIEX has your gene therapy research covered.
Through the precision analytics of SCIEX CE and LC-MS/MS technology, your laboratory will benefit from flexible workflows to get the answers you need when you need them most. SCIEX offers multiple kit-based chemistries to assess the quality and impurities of nucleic acids through the use of ultrasensitive fluorescence detection.
Discover ways to accelerate your gene therapy and oligonucleotide development by getting the right answers the first time, through precise analytics you can trust.
Discover solutions for characterization and quantification of oligonucleotides that will offer you faster candidate selection and shorter development time.
Assess the quality and safety of your adeno-associated virus (AAV) capsid proteins confidently to bring your drug to market faster.
Analyze a wide range of nucleic acids and plasmids with highly sensitive, automated and robust workflows.
Single Based Extension (SBE) SNP starter kits multiplex up to 10 SNPs in a single reaction with high accuracy and reproducibility by utilizing 4 different labeled ddNTPs for each target alleles.
The XP-PCR gene expression profiling assay allows your lab to identify and quantify target of interest mRNA quickly with the ability to analyze up to 30 gene targets in a single reaction.
As the technologies for manufacturing and analysis of gene therapy products continue to evolve, it’s important to keep up to date on growing industry trends and analytical advancements. This compendium can help advance your gene therapies and oligonucleotide therapeutics to the next level with the latest tools and methods.